丙型肝炎研究进展

被引：17

作者：

魏来 ^{[1
,2
]}

机构：

[1] 北京大学人民医院

[2] 北京大学肝病研究所

来源：

中国继续医学教育 | 2010年 / 2卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R512.63 [];

学科分类号：

摘要：

<正>1概述全球约有1.7亿丙型肝炎病毒(HCV)感染者,每年因HCV感染而死亡者高达28万人。因HCV感染导致的肝硬化、失代偿以及肝细胞癌已经成为发达国家肝移植的最主要原因,疾病负担显著增加。

引用

页码：9 / 17+83 +83

页数：10

共 12 条

[1]

Peginterferon alfa-2b and Ribavirin: Effective in Patients With Hepatitis C Who Failed Interferon alfa/Ribavirin Therapy [J].

Poynard, Thierry ;

Colombo, Massimo ;

Bruix, Jordi ;

Schiff, Eugene ;

Terg, Ruben ;

Flamm, Steven ;

Moreno-Otero, Ricardo ;

Carrilho, Flair ;

Schmidt, Warren ;

Berg, Thomas ;

McGarrity, Thomas ;

Heathcote, E. Jenny ;

Goncales, Fernando ;

Diago, Moises ;

Craxi, Antonio ;

Silva, Marcelo ;

Bedossa, Pierre ;

Mukhopadhyay, Pabak ;

Griffel, Louis ;

Burroughs, Margaret ;

Brass, Clifford ;

Albrecht, Janice .

GASTROENTEROLOGY, 2009, 136 (05) :1618-1628

[2]

1042 EFFICACY AND SAFETY RESULTS OF ALBINTERFERON ALFA-2B IN COMBINATION WITH RIBAVIRIN IN INTERFERON-ALFA TREATMENT NAIVE PATIENTS WITH GENOTYPE 2 OR 3 CHRONIC HEPATITIS C.[J].D. Nelson;Y. Benhamou;W.L. Chuang;E. Lawitz;R. Flisiak;M. Rodriguez-Torres;V. Bain;K. Patel;P.W. Cronin;E. Pulkstenis;G.M. Subramanian;J.G. McHutchison.Journal of Hepatology.2009,

[3]

4 HCV SPRINT-1 FINAL RESULTS: SVR 24 FROM A PHASE 2 STUDY OF BOCEPREVIR PLUS PEGINTRON? (PEGINTERFERON ALFA-2B)/RIBAVIRIN IN TREATMENT- NAIVE SUBJECTS WITH GENOTYPE-1 CHRONIC HEPATITIS C.[J].P. Kwo;E. Lawitz;J. McCone;E. Schiff;J. Vierling;D. Pound;M. Davis;J. Galati;S. Gordon;N. Ravendhran;L. Rossaro;F. Anderson;I. Jacobson;R. Rubin;K. Koury;C. Brass;E. Chaudhri;J. Albrecht.Journal of Hepatology.2009,

[4]

1041 EFFICACY AND SAFETY OF ALBINTERFERON ALFA-2B IN COMBINATION WITH RIBAVIRIN IN TREATMENT- NAIVE; CHRONIC HEPATITIS C GENOTYPE 1 (CHC G1) PATIENTS.[J].S. Zeuzem;M. Sulkowski;E. Lawitz;V. Rustgi;Y. Lurie;M. Grigorescu;A. Muir;P. Cronin;E. Pulkstenis;M. Subramanian;J. McHutchison.Journal of Hepatology.2009,

[5]

14 EFFICACY AND SAFETY OF WEIGHT-BASED REGIMENS OF TARIBAVIRIN OR RIBAVIRIN; GIVEN WITH PEGINTERFERON ALFA-2B; AT 12 WEEKS AFTER TREATMENT (SVR12) IN NAIVE PATIENTS WITH GENOTYPE 1 CHRONIC-HEPATITIS C.[J].F. Poordad;E. Lawitz;R. Pozza;M. Shiffman;B. Bacon;E. Godofsky;D. Halliman;J. Heise;E. Chun;J. Hammond.Journal of Hepatology.2009,

[6]

Incidence of Hepatocellular Carcinoma and Associated Risk Factors in Hepatitis C-Related Advanced Liver Disease [J].

Lok, Anna S. ;

Seeff, Leonard B. ;

Morgan, Timothy R. ;

Di Bisceglie, Adrian M. ;

Sterling, Richard K. ;

Curto, Teresa M. ;

Everson, Gregory T. ;

Lindsay, Karen L. ;

Lee, William M. ;

Bonkovsky, Herbert L. ;

Dienstag, Jules L. ;

Ghany, Marc G. ;

Morishima, Chihiro ;

Goodman, Zachary D. .

GASTROENTEROLOGY, 2009, 136 (01) :138-148

[7]

Diagnosis, Management, and Treatment of Hepatitis C: An Update [J].

Ghany, Marc G. ;

Strader, Doris B. ;

Thomas, David L. ;

Seeff, Leonard B. .

HEPATOLOGY, 2009, 49 (04) :1335-1374

[8]

104 BOCEPREVIR (B) COMBINATION THERAPY IN NULL RESPONDERS (NR): RESPONSE DEPENDENT ON INTERFERON RESPONSIVENESS.[J].E. Schiff;F. Poordad;I. Jacobson;S. Flamm;B. Bacon;E. Lawitz;S. Gordon;J. McHutchison;R. Ghalib;T. Poynard;M. Sulkowski;C. Trepo;M. Rizzetto;S. Zeuzem;P. Marcellin;P. Mendez;C. Brass;J.K. Albrecht.Journal of Hepatology.2008,

[9]

3 COLCHICINE VERSUS PEG-INTERFERON ALFA 2B LONG TERM THERAPY: RESULTS OF THE 4 YEAR COPILOT TRIAL.[J].N.H. Afdhal;R. Levine;R. Brown;B. Freilich;M. O'Brien;C. Brass.Journal of Hepatology.2008,

[10]

Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose Peginterferon [J].

Di Bisceglie, Adrian M. ;

Shiffman, Mitchell L. ;

Everson, Gregory T. ;

Lindsay, Karen L. ;

Everhart, James E. ;

Wright, Elizabeth C. ;

Lee, William M. ;

Lok, Anna S. ;

Bonkovsky, Herbert L. ;

Morgan, Timothy R. ;

Ghany, Marc G. ;

Morishima, Chihiro ;

Snow, Kristin K. ;

Dienstag, Jules L. .

NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (23) :2429-2441

← 1 2 →